MYOV
Vanguard Group’s Myovant Sciences Ltd. MYOV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-831,250
| Closed | -$22.4M | – | 4606 |
|
2022
Q4 | $22.4M | Buy |
831,250
+9,409
| +1% | +$254K | ﹤0.01% | 2569 |
|
2022
Q3 | $14.8M | Sell |
821,841
-37,314
| -4% | -$670K | ﹤0.01% | 2761 |
|
2022
Q2 | $10.7M | Buy |
859,155
+76,118
| +10% | +$946K | ﹤0.01% | 2957 |
|
2022
Q1 | $10.4M | Sell |
783,037
-5,123
| -0.6% | -$68.2K | ﹤0.01% | 3122 |
|
2021
Q4 | $12.3M | Sell |
788,160
-12,385
| -2% | -$193K | ﹤0.01% | 3110 |
|
2021
Q3 | $18M | Buy |
800,545
+26,228
| +3% | +$589K | ﹤0.01% | 2922 |
|
2021
Q2 | $17.6M | Buy |
774,317
+15,738
| +2% | +$358K | ﹤0.01% | 2914 |
|
2021
Q1 | $15.6M | Buy |
758,579
+610,261
| +411% | +$12.6M | ﹤0.01% | 2922 |
|
2020
Q4 | $4.1M | Sell |
148,318
-68,145
| -31% | -$1.88M | ﹤0.01% | 3444 |
|
2020
Q3 | $3.04M | Buy |
216,463
+74,155
| +52% | +$1.04M | ﹤0.01% | 3359 |
|
2020
Q2 | $2.93M | Buy |
142,308
+7,111
| +5% | +$147K | ﹤0.01% | 3319 |
|
2020
Q1 | $1.02M | Buy |
135,197
+4,829
| +4% | +$36.4K | ﹤0.01% | 3485 |
|
2019
Q4 | $2.02M | Buy |
130,368
+8,796
| +7% | +$136K | ﹤0.01% | 3447 |
|
2019
Q3 | $632K | Sell |
121,572
-2,184
| -2% | -$11.4K | ﹤0.01% | 3764 |
|
2019
Q2 | $1.12M | Buy |
+123,756
| New | +$1.12M | ﹤0.01% | 3641 |
|
2017
Q2 | – | Sell |
-29,958
| Closed | -$352K | – | 4088 |
|
2017
Q1 | $352K | Buy |
29,958
+1,440
| +5% | +$16.9K | ﹤0.01% | 3811 |
|
2016
Q4 | $354K | Buy |
+28,518
| New | +$354K | ﹤0.01% | 3798 |
|